Progenika Biopharma LPLchip obtains CE mark
According to Progenika Biopharma, the diagnostic test rapidly diagnoses patients with complete and partial lipoprotein lipase deficiency (LPLD) and has been developed under an agreement with Amsterdam Molecular
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.